#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA933562	B	Inhibition of human beta hexosaminidase	Homo sapiens	2		single protein format	Scientific Literature
2.	ALA986741	B	Increase in thermostability of beta Hex A betaR505Q mutant isolated from Sandhoff disease patient assessed as residual enzyme activity at 3 ug/ml at 37 degC after 30 mins relative to control	Homo sapiens	1		single protein format	Scientific Literature
3.	ALA986742	B	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
4.	ALA986743	B	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
5.	ALA986744	B	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
6.	ALA986745	B	Pharmacological chaperone effect on beta Hex A beta-C137Y/C137Y mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
7.	ALA986746	B	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
8.	ALA986747	B	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
9.	ALA986748	B	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
10.	ALA986749	B	Pharmacological chaperone effect on beta Hex A beta-T150P/P417L mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
11.	ALA986754	B	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
12.	ALA983111	B	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
13.	ALA983112	B	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
14.	ALA983113	B	Pharmacological chaperone effect on beta Hex A beta-P417L/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
15.	ALA983118	B	Pharmacological chaperone effect on beta Hex A beta-P504S/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
16.	ALA983119	B	Pharmacological chaperone effect on beta Hex A beta-P504S/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
17.	ALA983120	B	Pharmacological chaperone effect on beta Hex A beta-P504S/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
18.	ALA983121	B	Pharmacological chaperone effect on beta Hex A beta-P504S/delta16kb mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
19.	ALA983122	B	Activation of on beta Hex A beta C137Y/C137Y mutant in postnuclear supernatant of fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity per mg of protein at 3 mg/ml by relative to control	Homo sapiens	1		single protein format	Scientific Literature
20.	ALA983123	B	Activation of on beta Hex A beta C137Y/C137Y mutant in postnuclear supernatant of fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity per mg of protein at 3 mg/ml by relative to control	Homo sapiens	1		single protein format	Scientific Literature